Think you know a lot about cannabis and it’s history? Could you relate the ‘history of hemp’, thousands of years worth of human experience, in just four minutes and twenty seconds?
Comedian and pot activist extraordinaire Steve Berke’s 4 Twenty Today production company’s first video ‘History of Marijuana in Four Minutes and Twenty Seconds’ achieves such in high fashion and invoking laughter all the way.
Two of Steve’s previous pro-cannabis law reform pot song parodies are found here, the Macklemore parody has been seen by almost 14 million viewers:
The next production of 4 Twenty Today is set for release on September 8th (an absolutely hysterical parody of a classic American movie musical!), which is meant to correspond as being supportive for this fall’s big election in Florida on Amendment Two (which will legalize medical access for qualifying patients if 60% of the voters approve the initiative).
First and foremost, Hempfest is truly an enormous undertaking that requires several days of long hours to assemble the stages and hundreds of individual exhibitor and vendor booths; three days of long hours to manage, including a security team to guard the park overnight and provisions to feed the hundreds of volunteers each day; and then several days of equally long hours to disassemble everything, clean the grounds and replace any damaged turf.
And keep in mind this is an all-volunteer event sponsored by Seattle Events, a not-for-profit corporation, and is also free to the public. The event costs the Hempfest organization nearly $900,000 to put on, and that money is raised largely from vendors, exhibitors and sponsors. The volunteer effort is headed by Hempfest co-founder and Executive Director Vivian McPeak. McPeak leads a core group of volunteers who meet year around to plan for the next Hempfest, and who run a downtown store called Hempfest Central selling all sorts of hemp-based products.
There are three primary stages (the Share Parker Memorial Main Stage; the Peter McWilliams Memorial Stage; and the Ralph Seeley Memorial Stage, all named for beloved legalization activists who are no longer with us) spread along a narrow piece of parkland called the Myrtle Edwards Park. The park extends more than a mile along the downtown Seattle waterfront, from which an array of bands perform each day, with several speakers scheduled for brief 5-minute speeches between music sets (while the next band is setting-up). Some of the prominent speakers this year included Congressman Dana Rohrabacher from CA, former New Mexico Governor Gary Johnson, Seattle City Attorney Pete Holmes and public television travel guru and author (and NORML board member) Rick Steves.
Earlier today, the Democratic Party of Oregon came out in support of Measure 91, which would legalize and regulate the adult use, cultivation, and sale of marijuana in the state.
These endorsements were made by a “voting body comprised of the State Central Committee delegates, alternates, and associates.” A measure required a two-thirds vote for or against for the Party to take an official position.
In a press release highlighting their supportive position, the Democratic Party of Oregon stated that “a majority of Americans and large majority of Democrats now support state regulation of legal marijuana use. Measure 91 is the right approach to legalization in Oregon, strictly regulating use while funding law enforcement and schools. Vote Yes on 91.”
You can read the full release here.
You can learn more about Measure 91, including ways you can donate or volunteer, by visiting their website here.
NORML will be providing much more coverage on this and other ballot initiatives as election season heats up. Stay tuned.
As I prepared to leave for the Seattle Hempfest, a lovely celebration of all things related to marijuana, I could not help but think about what a wonderful time it is right now for those of us who smoke marijuana. We have the best quality marijuana in the world grown right here in the US, and even in those regions of the country that do not yet offer legal marijuana, the selection of different strains on the black market is outstanding. Of course, in those states with some version of legal marijuana, that selection is also conveniently available in retail outlets (at least for those who qualify).
When I began smoking marijuana in the mid-1960s, the question we generally asked the dealer-man was simple: do you have anything available? It was a simple yes-or-no question; and seldom did he have more than one or two strains. And worst of all, during the late summer and early fall, while we were waiting for the marijuana harvest to finish and work its way through the inefficient black market network from field to consumer, most years we experienced what we called a “drought.” During these droughts, there was simply no marijuana available, or at least nothing other than ditchweed, which was not worth smoking. Those dry periods would usually last for several weeks. But eventually we would get the word that the supply system was once again working, and we could again stock-up with a supply of adequate, but seldom great weed.
As best I can recall, I generally paid about $60 per ounce, so the cost was affordable, and there was usually an even less expensive version for those who were looking for a bargain, although I think most of that lower quality marijuana was likely headed for the college campuses all across America. According to a recent article published by the IvyGate website, citing a review of pot prices at all Ivy League schools published by the Yale Daily News in 1971, prices at the Ivy League colleges at the time were as low $8 and as high as $25 (for the best quality, usually obtained from Vietnam vets) per ounce. And the quality of what we then thought of as good marijuana would not compare favorably with what we routinely get today, whether from the black market or from a legal market.
The administration of a single dose of whole-plant cannabis via a thermal-metered inhaler is effective and well tolerated among patients suffering from neuropathy (nerve pain), according to clinical trial data published online ahead of print in the Journal of Pain and Palliative Care Pharmacotherapy.
Israeli investigators assessed the efficacy of a novel, portable metered-dose cannabis inhaler in eight subjects diagnosed with chronic neuropathic pain. Researchers reported that the device administered an efficient, consistent, and therapeutically effective dosage of cannabinoids to all participants.
They concluded, “This trial suggests the potential use of the Syqe Inhaler device as a smokeless delivery system of medicinal cannabis, producing a delta-9-THC pharmacokinetic profile with low inter-individual variation of (maximum drug/plasma concentrations), achieving pharmaceutical standards for inhaled drugs.”
A series of clinical trials conducted by investigators affiliated with the Center for Medicinal Cannabis Research at the University of California, San Diego previously determined that the inhalation of whole-plant cannabis is efficacious in the treatment of neuropathic pain.
Full text of the study, “The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: A phase 1a study,” will appear in the Journal of Pain and Palliative Care Pharmacotherapy.